Corporate News 15-Nov-22
Syngene's biologics facility successfully completes USFDA's pre-approval inspection
Syngene International announced that t the US Food and Drug Administration (FDA) has conducted its pre-approval inspection of the Biologics facility at Bangalore from 07 November 2022 till 15 November 2022. The inspection was completed successfully without 483 observations.
Previous News
Syngene International
( Results - Analysis 21-Jul-22 11:00 )
Syngene International to hold AGM
( Corporate News - 28-Apr-22 18:22 )
Syngene Intl declines after trimming revenue guidance; Q2 PAT rises 14% YoY
( Hot Pursuit - 18-Oct-23 09:28 )
Syngene International to hold AGM
( Corporate News - 27-Apr-23 12:48 )
Syngene International standalone net profit rises 5.86% in the December 2018 quarter
( Results - Announcements 23-Jan-19 16:19 )
Board of Syngene International approved allotment of 20 crore bonus shares
( Corporate News - 14-Jun-19 16:16 )
Syngene International to hold AGM
( Corporate News - 28-Jun-19 17:14 )
Syngene International expands ongoing collaboration with Bristol-Myers Squibb
( Corporate News - 14-Nov-17 09:26 )
Syngene International gains after posting good Q4 results
( Hot Pursuit - 27-Apr-16 12:48 )
Volumes jump at Monsanto India Ltd counter
( Hot Pursuit - 08-Apr-19 14:30 )
Syngene International
( Results - Analysis 25-Jul-24 10:15 )
Other Stories
Gujarat Natural Resources to convene board meeting
05-Oct-24 17:43
Narmada Macplast Drip Irrigation Sys. to convene board meeting
05-Oct-24 17:43
Grill Splendour Services to conduct board meeting
05-Oct-24 17:43
Consolidated Construction Consortium to hold board meeting
05-Oct-24 17:43
Visagar Polytex to announce Quarterly Result
05-Oct-24 17:42
GNA Axles to convene board meeting
05-Oct-24 17:42
Fidel Softech to conduct board meeting
05-Oct-24 17:42
Rita Finance & Leasing announces board meeting date
05-Oct-24 17:42
Pelatro to conduct EGM
05-Oct-24 17:36
Thinkink Picturez to hold AGM
05-Oct-24 17:35
Back
Top
